Source: Zacks

Quest Diagnostics: DGX Stock Gains Following the Launch of New AD-Detect Blood Test

Quest Diagnostics introduces AD-Detect Abeta, a new laboratory blood test, to detect Alzheimer's disease without any PET imaging and cerebral spinal fluid testing.

Read full article »
Annual Revenue
$5.0-10B
Employees
50-100K
James Davis's photo - President & CEO of Quest Diagnostics

President & CEO

James Davis

CEO Approval Rating

63/100

Read more